Liver biopsy vs. fibroscan for donor evaluation
Part of Digestive system clinical trials.
This trial compares two ways to check the health of a liver before donation: a traditional liver biopsy versus a non-invasive scan called FibroScan with CAP. The goal is to see if the scan can replace the biopsy for donor evaluation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are being considered as a liver donor for transplant
- You are willing to undergo a FibroScan with CAP test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
This study is testing a new way to use a FibroScan (a non-invasive liver scanner) with a single probe to measure liver health in people with chronic liver disease. If you have a long-term liver condition, this trial may help improve how liver exams are done.
This trial uses a blood test (FIB-4) to find liver scarring (fibrosis) in people who haven't been tested before. It aims to catch advanced liver disease early, which can help you get treatment sooner.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This trial uses a special ultrasound (Fibroscan) to check your liver health and see if you can safely reduce your anti-rejection medications. It is for people who are at least 2 years past a liver transplant and whose liver is working well.
Hear when a new Non-invasive Donor Liver Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.